Suicide is a prominent public health problem. Its aetiology is complex, and the brain-derived neurotrophic factor (BDNF) has been implicated. We performed the first meta-analysis of the functional BDNF marker Val 66 Met (rs6265, 196G>A) in suicidal behaviour using data from 11 previously published samples plus our present sample (total n=3352 subjects, 1202 with history of suicidal behaviour. The meta-analysis including all 12 studies showed a trend for the Met-carrying genotypes and Met allele conferring risk for suicide (random-effects model p=0.096 ; OR Met-carrier =1.13, 95 % CI 0.98-1.30, and random-effects model p=0.032 ; OR Met =1.16, 95 % CI 1.01-1.32, respectively). Furthermore, we found the Met allele and the Met allele-carrying genotypes to be associated with history of suicide attempt (eight studies ; allelic meta-analysis -random-effects model : p=0.013 ; fixed-effects model : p=0.006 ; genotypic metaanalysis -random-effects model : p=0.017 ; fixed-effects model : p=0.008). Taken together, the results from our study suggest that BDNF Val 66 Met is involved in suicidality. Further studies are required to elucidate its role in suicidal behaviour.
Introduction
The World Health Organization estimates that almost one million deaths each year are attributable to suicide, and suicide attempt is close to 20 times more common than suicide completion. Thus, understanding the impact of the interplay between molecular and clinical factors behind suicidal attempt is a major public health concern. Approximately 90 % of suicide victims suffer from at least one psychiatric disorder. Family and twin studies support a strong genetic basis of suicidal behaviour (Bondy et al. 2006 ). The concordant phenotype in twin studies includes both completed suicide and suicide attempts (Bondy et al. 2006) , and their heritability appears to be at least partially independent of psychiatric disorders (Bondy et al. 2006) . A meta-analysis of excess mortality rates in schizophrenia (SCZ) by Brown (1997) found suicides to be its leading cause, accounting for 28 % of excess deaths in SCZ.
Brain-derived neurotrophic factor (BDNF) expression has been found altered in suicide attempters and victims (reviewed in Dwivedi, 2010) . Recent genetic studies of the functional Val 66 Met (rs6265, 196G>A) polymorphism (Egan et al. 2003 ) and suicide have yielded mixed results Spalletta et al. 2010 ; Zarrilli et al. 2009 ). A number of research groups found that patients with the Met allele were at increased risk for suicide in the context of various psychiatric disorders Iga et al. 2007 ; Kim et al. 2008 ; Sarchiapone et al. 2008 ). In the current study, we aimed to perform a meta-analysis of the functional Val 66 Met polymorphism in suicidal behaviour, adding data from our sample of SCZ patients.
Patients and methods

Subjects
The research subjects were recruited from the Centre for Addiction and Mental Health. We included only subjects of European ancestry in this study, as indicated by self-reported ethnicities of grandparents. The Structured Clinical Interview for DSM-IV (SCID-I) was administered as the primary diagnostic tool. A clinical summary of detailed information about sequence, context, and severity of symptoms was prepared for each patient. We recruited 196 SCZ probands with data on suicide attempt.
Genomic DNA was purified from whole-blood samples using a non-enzymatic method described previously (Zai et al. 2010a ). Genotyping of the Val 66 Met polymorphism was done using TaqMan genotyping assay (Applied Biosystems, USA) as described previously (Zai et al. 2010a ).
Ethical considerations
The scientific work described in this article complies with the current laws of Canada and the USA, as well as the ethical standards established in the 1964 Declaration of Helsinki. Informed consent was obtained before patients ' participation, and this study was approved by the Ethics Committee of the Centre for Addiction and Mental Health.
Meta-analysis
We performed PubMed searches using the key terms 'BDNF ', ' Val 66 Met ', ' suicide ', ' aggressive', and 'genetics '. We included papers examining Val 66 Met for association with suicide attempt or completion, with raw genotype counts available for subjects with suicidal behaviour and subjects without. We performed the meta-analysis using Stata version 8 (StataCorp, USA) as described previously (Zai et al. 2010b ). Briefly, the pooled odds ratio was calculated using the inverse variance method under the fixedeffects model, and the DerSimonian and Laird method under the random-effects model within Stata. Meta-regression was performed to assess the effects of age, percentage males, and ethnicity on the results from the meta-analysis. Publication bias was estimated using Begg's and Egger's tests. The effect of each study was ascertained by sensitivity analysis.
Results
Meta-analysis of BDNF Val 66 Met in suicidal behaviour
Our literature search using key terms ' BDNF ', 'suicide ', and 'genetics' yielded 22 studies. We included eight previously published studies that gave genotype counts for subjects with suicidal behaviour and subjects without suicidal behaviour. We found the article by Pregelj et al. (2011) using the search terms ' Val 66 Met ' and 'suicide ', and the article by Spalletta et al. (2010) using the search terms 'Val 66 Met ' and 'aggressive '. The genotype counts in suicide attempters and non-attempters for the Perroud et al. (2009) study were provided by the corresponding author. The genotype counts in suicide attempters and non-attempters for the de Luca et al. (2011) study were included as part of the present study. In total, we obtained genotypes for 3352 subjects, 1202 of which have a history of suicidal behaviour. The demographic information of each study is shown in Table 1 . Two of the studies reported on suicide completion vs. healthy controls Zarrilli et al. 2009 ) and one study did not specify on suicidal behaviour . Of the ten studies where suicide cases were matched with non-suicidal psychiatric controls, the primary diagnosis was SCZ in three samples, and either bipolar disorder or major depression in the remaining seven samples.
The meta-analysis including all 12 studies showed a trend for the Met-carrying genotypes and Met allele conferring risk for suicide ( Fig. 1 (Table 2) . Sensitivity analysis did not reveal a significant effect of removal of any single study on the pooled odds ratio (Table 2) . Ethnicity and frequency appear to be contributing to the results of the genotypic meta-analysis (Table 1) . Thus, we analysed studies on patients of East Asian and European ancestry separately (Table 2) . We found the association was stronger within the East Asian (Chinese, Korean, Japanese) samples (n=755, of which 171 were suicide attempters : random-effects model p=0.035 ; OR Met-carrier =1.60, 95 % CI 1.03-2.49, and random-effects model p=0.006 ; OR Met =1.49, 95 % CI 1.12-1.97). When we removed one study where the genotype frequency was out of Hardy-Weinberg equilibrium (HWE) ), one study with unspecified suicidal behaviour , and two studies with a different case-control matching strategy in terms of suicide phenotype (suicide completion) and controls (healthy controls instead of psychiatric controls) Zarrilli et al. 2009 ), we found that the between-study heterogeneity diminished [p (Met- Table 2) . There is no evidence of significant publication bias associated with the genotypic and allelic analyses.
Discussion
To our knowledge, this is the first meta-analytical study of the BDNF gene with suicidal behaviour. The genotype data from Kohli et al. (2010) was not available for us to include in this meta-analysis. While data being not available does not represent a clear bias, bias from this kind of omission cannot be ruled out. Because the secondary analyses with different ethnicities and suicide attempt are related to the primary analysis in all 12 studies, we did not correct for these subgroup analyses. In marked contrast to the results from our SCZ sample, the meta-analysis of the 12 studies with available genotypes indicated that the BDNF rs6265 Val 66 Met marker has statistically significant effect on risk of suicide, with the Met allele and Met-allele carriers at risk for suicidal behaviour. The association may also be stronger in the East Asian population, although we may not have enough European samples to detect an association. The results became more robust when we removed four studies -one study in which the genotype frequency is out of HWE , another study where the suicidal behaviour is not specified , and the third and fourth studies where suicide completers are matched to healthy controls Zarrilli et al. 2009 ). Results from Pregelj et al. (2011) and Zarrilli et al. (2009) , for example, have been criticized since they could have been influenced by an association between Val 66 Met and the psychiatric disorder as opposed to suicidal behaviour. Similarly, results from Iga et al. (2007) could have been influenced by the inclusion of suicide ideation in the classification of suicidal behaviour. The study by Vincze et al. (2008) may have sampling bias and other technical issues. The refined sample exhibits an overall statistically significant association between the Met allele and risk (Lyons et al. 1999) . Environmental stress has been shown to reduce BDNF levels (reviewed in Dwivedi, 2010) . Epigenetic interrogation of the BDNF gene may provide insight into the effect of the environment on BDNF expression and add to the genetic findings (De Luca et al. 2011 ; Keller et al. 2010) . Given that the low-functioning BDNF Met allele appears to be a risk factor for suicidality, it could be hypothesized that a compound that increases BDNF function may be helpful for suicide prevention (Schmidt & Duman, 2010) . Nonetheless, further replication studies and functional analyses are required to better understand how decreased BDNF signalling may be contributing to suicidal behaviour. Spalletta et al. 2010 Pregelj et al. 2011 Perroud et al. 2009 Zarrilli et al. 2009 Kim et al. 2008 Sarchiapone et al. 2008 Vincze et al. 2008 Iga et al. 2007 Hwang et al. 2006 Hong et al. 2003 Overall ( 
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